|
|
 |
 |
 |
|
|
|||
|
||||
|
||||
Re: pharmacologic tocolysisFrom: DoctorJoe@aol.comSat Nov 29 17:14:04 1997
In a message dated 11/29/97 11:36:16 AM, you wrote: <<I *THINK* you're wrong. I looked up the register of trial on the Cochrane database (the list of trials not meta-analyses) and those with abstracts list subjects either as women in preterm labour showing cervical changes or as merely in preterm labour (unspecified). Clearly one would need to read all of the papers to be certain. My uderstanding had long been that preterm labourers without changes had been included in many studies. Anyone lese *KNOW*?>> Well, all of the "accepted" research (e.g., the Canadian ritodrine study) use something like "cervical dilation of 2 cm or more" etc, etc. So you might have EARLY cervical dilation and make more headway with tocolytics than in patients who are in rip roaring labor already and are too far gone to stop. (In fact, in some of the Canadian patients, they already had ROM... not a good tocolytic patient to me...). The study I liked was by Zalar in the green journal a year or so ago. I'll have to look it up again. Joe P.
|
|
Return to
|
Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Mon Nov 2 05:25:25 2009 |
The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.